The clinical journey and healthcare resources required for dialysis access of end-stage kidney disease patients during their first year of hemodialysis.
Pei HoNur Nabila Farhana Binte Taufiq Chong Ah HooYi Xin ChengLingyan MengDarryl Chai Min ShenBoon Wee TeoValerie MaCarol Anne HargreavesPublished in: The journal of vascular access (2022)
With comparable cost, a pre-emptive approach enables avoidance of tunneled CVC. Tunneled CVC only access format incurred lower cost and is suitable for carefully selected patients. Successful maturation of SCVA greatly affects patients' clinical journey and healthcare cost.